OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation

Virchows Archiv

Volumn 459, Issue 2, 2011, Pages 141-146

  Vasuri, Francesco ^a   Golfieri, Rita ^a   Fiorentino, Michelangelo ^a   Capizzi, Elisa ^a   Renzulli, Matteo ^a   Pinna, Antonio D ^a   Grigioni, Walter F ^a   D'Errico Grigioni, Antonia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cholangiocellular carcinoma; Gd EOB DTPA; Hepatocellular carcinoma; Keratin 19; Keratin 7; Organic anion transporter peptide

Indexed keywords

CAPECITABINE; CYTOKERATIN 19; CYTOKERATIN 7; GEMCITABINE; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER PEPTIDE 1B1; ORGANIC ANION TRANSPORTER PEPTIDE 1B3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATIN-19; KERATIN-7; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80052425120     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1099-5     Document Type: Article

References (28)

1. V Mazzaferro JM Llovet R Miceli S Bhoori M Schiavo L Mariani T Camerini S Roayaie ME Schwartz GL Grazi, et al. 2009 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 35 43 19058754 10.1016/S1470-2045(08)70284-5
2. LB Xu J Wang C Liu HW Pang YJ Chen QJ Ou JS Chen 2010 Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery World J Gastroenterol 16 5257 5262 21049561 10.3748/wjg.v16.i41.5257
3. M Hayashi O Matsui K Ueda Y Kawamori T Gabata M Kadoya 2002 Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood SUPPL.y evaluated with CT during intrarterial injection of contrast material Radiology 225 143 149 12354998 10.1148/radiol.2251011298
4. M Hayashi O Matsui K Ueda Y Kawamori M Kadoya J Yoshikawa T Gabata T Takashima A Nonomura J Nakanuma 1999 Correlation between the blood SUPPL.y and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium AJR Am J Roentgenol 172 969 976 10587130 1:STN:280:DC%2BD3c%2Flt1CisQ%3D%3D (Pubitemid 29505622)
5. S Leoni F Piscaglia R Golfieri V Camaggi G Vidili P Pini L Bolondi 2010 The impact of vascular and non vascular findings on the non invasive diagnosis of small hepatocellular carcinoma based on EASL and AASLD criteria Am J Gastroenterol 105 599 609 19935786 10.1038/ajg.2009.654
6. Y Cui J König AT Nies M Pfannschmidt M Hergt WW Franke W Alt R Moll D Keppler 2003 Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma Lab Invest 83 527 538 12695556 1:CAS:528:DC%2BD3sXisFCjsLc%3D (Pubitemid 36457707)
7. A Kalliokoski M Niemi 2009 Impact of OATP transporters on pharmacokinetics Br J Pharmacol 158 693 705 19785645 10.1111/j.1476-5381.2009. 00430.x 1:CAS:528:DC%2BD1MXhsVSks7rE
8. M Oswald GA Kullak-Ublick G Paumgartner U Beuers 2001 Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis Liver 21 247 253 11454187 10.1034/j.1600-0676.2001.021004247.x 1:CAS:528: DC%2BD3MXmtVGnu7s%3D (Pubitemid 32677380)
9. H Kojima AT Nies J König W Hagmann H Spring M Uemura H Fukui D Keppler 2003 Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis J Hepatol 39 693 702 14568249 10.1016/S0168-8278(03)00410-0 1:CAS:528:DC%2BD3sXotVersbY%3D (Pubitemid 37372176)
10. M Dumont E Jacquemin C D'Hont C Descout D Cresteil D Haouzi M Desrochers B Stieger M Hadchouel S Erlinger 1997 Expression of the liver Na + -independent organic anion transporting polypeptide (oatp-1) in rats with bile duct ligation J Hepatol 27 1051 1056 9453431 10.1016/S0168-8278(97)80149-3 1:CAS:528:DyaK1cXksFKg (Pubitemid 27523964)
11. P Reimer EJ Rummeny K Shamsi T Balzer HE Daldrup B Tombach T Hesse T Berns PE Peters 1996 Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence Radiology 199 177 183 8633143 1:STN:280: DyaK283gtFyqug%3D%3D (Pubitemid 26098637)
12. M Narita E Hatano S Arizono A Miyagawa-Hayashino H Isoda K Kitamura K Taura K Yasuchika T Nitta I Ikai S Uemoto 2009 Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma J Gastroenterol 44 793 798 19404564 10.1007/s00535-009-0056-4 1:CAS:528:DC%2BD1MXotlehtrs%3D
13. B Hamm T Staks A Mühler M Bollow M Taupitz T Frenzel KJ Wolf HJ Weinmann L Lange 1995 Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 785 792 7754011 1:STN:280:DyaK2M3ntlGrsg%3D%3D
14. T Tsuboyama H Onishi T Kim H Akita M Hori M Tatsumi A Nakamoto H Nagano N Matsuura K Wakasa K Tomoda 2010 Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging-correlation with expression of sinusoidal and canalicular transporters and bile accumulation Radiology 255 824 833 20501720 10.1148/radiol.10091557
15. M Kinoshita M Miyata 2002 Underexpression of mRNA in human hepatocellular carcinoma focusing on eight loci Hepatology 36 433 438 12143053 10.1053/jhep.2002.34851 1:CAS:528:DC%2BD38XmsVansLk%3D (Pubitemid 34810364)
16. ML Vee V Lecureur B Stieger O Fardel 2009 Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6 Drug Metab Dispos 37 685 693 19074973 10.1124/dmd.108.023630
17. ML Vee P Gripon B Stieger O Fardel 2008 Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta Drug Metab Dispos 36 217 222 17991769 10.1124/dmd.107.016907 (Pubitemid 351185762)
18. SR Vavricka D Jung M Fried U Grützner PJ Meier GA Kullak-Ublick 2004 The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3beta in hepatocellular carcinoma J Hepatol 40 212 218 14739090 10.1016/j.jhep.2003.10.008 1:CAS:528:DC%2BD2cXltVCisw%3D%3D (Pubitemid 38115824)
19. PC Wu JW Fang VK Lau CL Lai CK Lo JY Lau 1996 Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications Am J Pathol 149 1167 1175 8863666 1:STN:280:DyaK2s%2FhslSmsQ%3D%3D (Pubitemid 26337236)
20. A Durnez C Verslype F Nevens J Fevery R Aerts J Pirenne E Lesaffre L Libbrecht V Desmet T Roskams 2006 The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin Histopathology 49 138 151 16879391 10.1111/j.1365-2559.2006.02468.x 1:STN:280:DC%2BD28vls1KrsQ%3D%3D (Pubitemid 44079697)
21. T Uenishi S Kubo T Yamamoto T Shuto M Ogawa H Tanaka S Tanaka K Kaneda K Hirohashi 2003 Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence Cancer Sci 94 851 857 14556657 10.1111/j.1349-7006.2003.tb01366.x 1:CAS:528:DC%2BD3sXpsFGhtL4%3D (Pubitemid 37406966)
22. A D'Errico P Baccarini M Fiorentino C Ceccarelli C Bonazzi A Ponzetto JY Scoazec AM Mancini WF Grigioni 1996 Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection Hum Pathol 27 599 604 8666372 10.1016/S0046-8177(96)90169-0 (Pubitemid 26187286)
23. F Zhang XP Chen W Zhang HH Dong S Xiang WG Zhang BX Zhang 2008 Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence Histopathology 52 224 232 18184271 10.1111/j.1365-2559.2007.02929.x 1:STN:280:DC%2BD1c%2Fit1aqtg%3D%3D
24. V Mazzaferro E Regalia R Doci S Andreola A Pulvirenti F Bozzetti F Montalto M Ammatuna A Morabito L Gennari 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 8594428 10.1056/NEJM199603143341104 1:STN:280: DyaK287nsFWltw%3D%3D (Pubitemid 26079803)
25. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 462 503 13160935 10.1002/1097- 0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E 1:STN:280: DyaG2c%2FotV2mtQ%3D%3D
26. ZD Goodman KG Ishak JM Langloss IA Sesterhenn L Rabin 1985 Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study Cancer 55 124 135 2578078 10.1002/1097-0142(19850101)55:1<124::AID- CNCR2820550120>3.0.CO;2-Z 1:STN:280:DyaL2M%2Fntl2mtA%3D%3D (Pubitemid 15198209)
27. M Roncalli YN Park L Di Tommaso 2010 Histopathological classification of hepatocellular carcinoma Dig Liver Dis 42S S228 S234 10.1016/S1590-8658(10) 60510-5
28. M Kudo 2010 Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology 78 SUPPL. 1 87 93 20616589 10.1159/000315235